Induction of p53-dependent and -independent mitochondrial death based on the BCL-2 profile in hematological malignancies
Project/Area Number |
17K09928
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Kochi University (2019-2020) Saga University (2017-2018) |
Principal Investigator |
KOJIMA KENSUKE 高知大学, 教育研究部医療学系臨床医学部門, 教授 (10332793)
|
Project Period (FY) |
2017-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 造血器腫瘍 / 分子標的治療 / BCL-2 / 薬剤耐性 / MCL-1 / p53 / 耐性 / シグナル伝達 / 細胞死 |
Outline of Final Research Achievements |
We have found that malignant hematopoietic cells have their own anti-apoptotic adaptation program irrespective for p53 status and obtain resistance against molecular target drugs via changing cellular BCL-2 profile, not through the selection of cells with newly obtaining genetic abnormalities.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究により、腫瘍特異的な分子標的治療をおこなった際の治療耐性機序として、長期的に生存依存性を示すBCL-2ファミリー・プロファイルを変えてゆくことで、ゲノム異常によらずがん細胞が薬剤耐性を獲得することを、具体的な造血器腫瘍モデルとともに見いだした。腫瘍シグナル変化の解析をおこなったところ一部は p53シグナルに干渉するものであったことから、p53シグナル活性化治療との併用など、新たな分子標的治療戦略として発展につながる結果であった。
|
Report
(5 results)
Research Products
(38 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Clinical impact of the CONUT score in patients with multiple myeloma2020
Author(s)
Okamoto S, Ureshino H*, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H, Nishioka A, Yamaguchi K, Kamachi K, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kawaguchi A, Sueoka E, Kimura S.
-
Journal Title
Ann Hematol
Volume: 99
Issue: 1
Pages: 113-119
DOI
Related Report
Peer Reviewed
-
[Journal Article] Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis.2019
Author(s)
Kidoguchi K, Yoshimura M, Kojima K*, Ureshino H, Egashira R, Yokoo M, Kai K, Egashira Y, Ohshima K, Ando T, Kimura S.
-
Journal Title
Ann Hematol
Volume: 98
Issue: 5
Pages: 1305-1307
DOI
Related Report
Peer Reviewed
-
[Journal Article] Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.2019
Author(s)
Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Kimura S.
-
Journal Title
Annals of Hematology
Volume: 98
Issue: 2
Pages: 465-471
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.2019
Author(s)
Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, Zhao R, St-Germain J, Heese LE, Egan G, Ruvolo VR, Barghout SH, Nishida Y, Hurren R, Ma W, Gronda M, Link T, Wong K, Mabanglo M, Kojima K, Andreeff M
-
Journal Title
Cancer Cell
Volume: 35
Issue: 5
Pages: 721-737
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] ipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia2019
Author(s)
Nii T, Prabhu VV, Ruvolo V, Madhukar N, Zhao R, Mu H, Heese L, Nishida Y, Kojima K, Garnett MJ, McDermott U, Benes CH, Charter N, Deacon S, Elemento O, Allen JE, Oster W, Stogniew M, Ishizawa J, Andreeff M.
-
Journal Title
Leukemia
Volume: 33
Issue: 12
Pages: 2805-2816
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
[Journal Article] Feasibility of the Imatinib Stop Study in the Japanese Clinical Setting: Delightedly Overcome CML Expert Stop TKI Trial (DOMEST Trial).2018
Author(s)
Fujisawa S, Ueda Y, Usuki K, Kobayashi K, Kondo E, Doki N, Nakao T, Kanda Y, Kosugi N, Kosug H, Kumagai T, Harada H, Shikami M, Maeda Y, Sakura T, Inokuchi K, Saito A, Nawa Y, Ogasawara M, Nishida J, Kondo T, Yoshida C, Kuroda H, Tabe Y, Maeda Y, Imajo K, Kojima K, Morita S, Komukai S, Kawaguchi A, Sakamoto J, Kimura S
-
Journal Title
International Journal of Clinical Oncology
Volume: 24
Issue: 4
Pages: 445-453
DOI
Related Report
Peer Reviewed
-
[Journal Article] Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.2018
Author(s)
Maeda A, Nishida Y, Weetall M, Cao L, Branstrom A, Ishizawa J, Nii T, Schober WD, Abe Y, Matsue K, Yoshimura M, Kimura S, Kojima K.
-
Journal Title
Oncotarget.
Volume: 19
Issue: 47
Pages: 28547-28560
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition.2018
Author(s)
Ishizawa J, Nakamaru K, Seki T, Tazaki K, Kojima K, Chachad D, Zhao R, Heese L, Ma W, Ma MCJ, DiNardo C, Pierce S, Patel KP, Tse A, Davis RE, Rao A, Andreeff M.
-
Journal Title
Cancer Res.
Volume: 78
Issue: 10
Pages: 2721-2731
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Predictive gene signatures determine tumor sensitivity to MDM2 inhibition.2018
Author(s)
Ishizawa J, Nakamaru K, Seki T, Tazaki K, Kojima K, Chachad D, Zhao R, Heese LE, Ma W, Ma MCJ, DiNardo CD, Pierce SA, Patel KP, Tse A, Davis RE, Rao A, Andreeff M.
-
Journal Title
Cancer Res.
Volume: in press
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells.2017
Author(s)
Nishida Y, Maeda A, Kim MJ, Cao L, Kubota Y, Ishizawa J, AlRawi A, Kato Y, Iwama A, Fujisawa M, Matsue K, Weetall M, Dumble M, Andreeff M, Davis TW, Branstrom A, Kimura S, Kojima K.
-
Journal Title
Blood Cancer J
Volume: 17
Issue: 2
Pages: e527-e527
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
[Presentation] The novel imipridone ONC212 highly synergizes with the BCL-2 inhibitor ABT-199 in AML and activates orphan receptor GPR132.2018
Author(s)
Nii T, Ishizawa J, Prabhu VV, Ruvolo V, Madhukar N, Zhao R, Mu H, Heese L, Kojima K, Garnett M, McDermott U, Benes C, Charter N, Deacon S, Elemento O, Allen J, Oster W, Stogniewand M, Andreeff M.
Organizer
018 American Association for Cancer Research (AACR) Annual Meeting
Related Report
Int'l Joint Research
-
-
-
[Presentation] Inhibition of Translation Initiation and Heat Shock Factor 1 (HSF1): A Novel Strategy Targeting FLT3 Double Mutant and Non-FLT3 Mutant AML Progenitor/Stem Cells2017
Author(s)
Jo Ishizawa, Ran Zhao, Lauren Heese, Alex Jaeger, Yuki Nishida, Rodrigo Jacamo, Kensuke Kojima, Man Chun John MA, Vivian Ruvolo, Dhruv Chachad, R. Eric Davis, William Devine, John A Porco Jr., Luke Whitesell and Michael Andreeff
Organizer
59th Annual Meeting and Exposition
Related Report
Int'l Joint Research
-
[Presentation] PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells2017
Author(s)
Liangxian Cao, Arthur Branstrom, John Baird, Christopher Trotta, Joseph Colacino, Marianne T. Santaguida, Diane Heiser, Mark Ma, Kensuke Kojima, Stuart Peltz, Edward O'Mara, Robert Spiegel and Marla Weetall
Organizer
59th Annual Meeting and Exposition
Related Report
Int'l Joint Research
-
[Presentation] The Novel Imipridone ONC212 Induces Pronounced Anti-Leukemia Effects in Vitro and In Vivo and Is Highly Synergistic with the BCL-2 Inhibitor ABT-1992017
Author(s)
Takenobu Nii, Jo Ishizawa, Varun Vijay Prabhu, Vivian Ruvolo, Neel Madhukar, Ran Zhao, Hong Mu, Lauren Heese, Kensuke Kojima, Mathew Garnett, Ultan McDermott, Cyril H Benes, Neil Charter, Sean Deacon, Olivier Elemento, Joshua E. Allen, Wolfgang Oster, Martin Stogniew and Michael Andreeff
Organizer
59th Annual Meeting and Exposition
Related Report
Int'l Joint Research
-
-
-
-